Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

VisionCare’s implantable telescope

This article was originally published in The Gray Sheet

Executive Summary

VisionCare Ophthalmic Technologies begins enrollment of a multi-center Phase II/III clinical trial of its IMT implantable miniature telescope. The pea-sized device is implanted in the eye under local anesthesia to provide magnification of 3.0x or 2.2x to aid patients with moderate to severe bilateral central vision impairment due to either dry or scar-stage wet age-related macular degeneration or Stargardt's macular dystrophy. The pivotal study will include about 200 patients at up to 30 U.S. sites...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT017749

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel